ST-elevation Myocardial Infarction (STEMI) Clinical Trials

8 recruitingLast updated: May 11, 2026

There are 8 actively recruiting st-elevation myocardial infarction (stemi) clinical trials across 7 countries. Studies span Not Applicable, Phase 4. Top locations include Belgrade, Serbia, Caserta, Italy, Catania, Italy. Updated daily from ClinicalTrials.gov.


ST-elevation Myocardial Infarction (STEMI) Trials at a Glance

8 actively recruiting trials for st-elevation myocardial infarction (stemi) are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Belgrade, Caserta, and Catania. Lead sponsors running st-elevation myocardial infarction (stemi) studies include Chen Jing, Henan Institute of Cardiovascular Epidemiology, and Azienda Ospedaliera "Sant'Andrea".

Browse st-elevation myocardial infarction (stemi) trials by phase

Treatments under study

About ST-elevation Myocardial Infarction (STEMI) Clinical Trials

Looking for clinical trials for ST-elevation Myocardial Infarction (STEMI)? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ST-elevation Myocardial Infarction (STEMI) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ST-elevation Myocardial Infarction (STEMI) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Drug-Eluting Balloon or Drug-Eluting Stent in Acute Myocardial Infarction: A Randomized Controlled Trial

ST-elevation Myocardial Infarction (STEMI)
Institute of Cardiovascular Diseases, Vojvodina598 enrolled5 locationsNCT06746233
Recruiting
Not Applicable

Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial Infarction

ST-elevation Myocardial Infarction (STEMI)
Saglik Bilimleri Universitesi200 enrolled1 locationNCT07427199
Recruiting
Not Applicable

Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction

ST-elevation Myocardial Infarction (STEMI)
Second Affiliated Hospital, School of Medicine, Zhejiang University1,244 enrolled1 locationNCT06742125
Recruiting
Not Applicable

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial

ST-elevation Myocardial Infarction (STEMI)Primary PCI
Chen Jing6,294 enrolled1 locationNCT07361783
Recruiting
Not Applicable

Intracoronary Hypothermia as a Prevention of Reperfusion Injury in Myocardial Infarction.

Myocardial InfarctionST-elevation Myocardial Infarction (STEMI)Reperfusion Injury+1 more
Tomsk National Research Medical Center of the Russian Academy of Sciences60 enrolled1 locationNCT06567249
Recruiting

Platelet Derived Growth Factor Receptor ß (PDGFRß) Imaging in Cardiac Fibrosis

ST-elevation Myocardial Infarction (STEMI)Heart Failure With Preserved Ejection Fraction (HFpEF)
Uppsala University30 enrolled1 locationNCT06956560
Recruiting

Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI)

Pollution; ExposureST-elevation Myocardial Infarction (STEMI)Microplastics+1 more
Azienda Ospedaliera "Sant'Andrea"130 enrolled10 locationsNCT06965023
Recruiting
Phase 4

Effect of Very Early and Rapid Lowering Cholesterol With Evolocumab on Left Ventricular Remodeling in Patients With Anterior STEMI Undergoing Primary PCI

ST-elevation Myocardial Infarction (STEMI)
Henan Institute of Cardiovascular Epidemiology330 enrolled6 locationsNCT05613426